• No results found

Rituximab Treatment in New and Refractory Thrombotic Thrombocytopenic Purpura (TTP) Patients: A Review

N/A
N/A
Protected

Academic year: 2020

Share "Rituximab Treatment in New and Refractory Thrombotic Thrombocytopenic Purpura (TTP) Patients: A Review"

Copied!
5
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1: Distribution of subjects according to the age
Table 3: Correlation between actual birth weight and estimated fetal weight in control group at gestational age 37 to 40 weeks

References

Related documents

Al- though osteoblast number in the trabecular bone de- creased, the level of OCN in the serum was increased at 2 weeks post-irradiation, suggesting that radiation exposure did

In two patients originating from one family, the hyperlysinemia was caused by a contiguous gene deletion syndrome affecting AASS and PTPRZ1.. Our findings illustrate the importance

As the donor site problems is concerned, the work of Wei [23] done on fifteen patients reconstructed with bilateral radial free forearm flap after surgical release of sub

Results: Thematic content analysis of the interviews resulted in 6 major themes, including (1) Familiarity with medication safety & adverse drug reaction concept (2) Current

BE: Bioequivalence; BW: Biowaiver; CD: Calendar days; CDDA: Cosmetics Devices and Drugs Authority; CDSCO: Central Drugs Standard Control Organization; CTD: Common technical

Deschauer M, Breunig F, Glocker FX, Vielhaber S, et al : Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2:

A small number of reports of rare, attenuated forms of CHS exist, with affected individuals exhibiting progressive neurodegenerative disease beginning in early adulthood with

In 14 cases, it was extended throughout the splanchnic district, whilst in 6 patients it involved mainly the ileum and the colon (right colon 2 cases; left colon 3 cases; entire colon